Search
News
Important Only
Nurexone Biologic’S U.S. Subsidiary Exo-Top And Florida-Based Bioxtek Sign Strategic Loi For Exosome Manufacturing And Commercialization
April 7 (Reuters) - Nurexone Biologic Inc NRX.V:NUREXONE BIOLOGIC’S U.S. SUBSIDIARY EXO-TOP AND FLORIDA-BASED BIOXTEK SIGN STRATEGIC LOI FOR EXOSOME MANUFACTURING AND COMMERCIALIZATIONNUREXONE BIOLOGIC INC - PARTIES TO NEGOTIATE STRATEGIC PARTNERSHIP FOR GMP MANUFACTURING AND COMMERCIALIZATION OF MS...Reuters
16 minutes ago
PRESS DIGEST-Canada - April 7
April 7 (Reuters) - The following are the top stories from selected Canadian newspapers. Reuters has not verified these stories and does not vouch for their accuracy.THE GLOBE AND MAIL- Vancouver-based Telus Corp T.TO reported a net increase of nearly 5,000 employees in 2025 but shed roughly 2,800 j...Reuters
23 minutes ago
Ukrainian drone strikes kill five, including child and parents at home, Russian officials say
MOSCOW, April 7 (Reuters) - Ukrainian drone strikes killed five civilians, including a 12-year-old boy and his parents, and struck a school in a part of southeastern Ukraine controlled by Russian forces, Russian officials said on Tuesday. The 12-year-old boy and his parents were killed in their apar...Reuters
24 minutes ago
Efforts to facilitate talks between US, Iran ongoing, Pakistani sources say
Iran strike on Saudi Arabia threatens to derail talks, sources sayPakistan mediates but faces risk due to pact with Saudi ArabiaIran demands end to US, Israeli strikes and compensation before peace talks, Iranian source says April 7 (Reuters) - Efforts to facilitate talks between the U.S. and Ira...Reuters
27 minutes ago
Edgebeam Wireless Acquires Sinclair’S Broadspan Distribution Platform To Accelerate Its National Data Delivery Network Leveraging Atsc 3.0
April 7 (Reuters) - Sinclair Inc SBGI.O:EDGEBEAM WIRELESS ACQUIRES SINCLAIR’S BROADSPAN DISTRIBUTION PLATFORM TO ACCELERATE ITS NATIONAL DATA DELIVERY NETWORK LEVERAGING ATSC 3.0SINCLAIR INC - TERMS OF DEAL NOT DISCLOSEDReuters
33 minutes ago
Evotec to receive $100 mln as Gilead acquires Tubulis
April 7 (Reuters) - German biotech company Evotec EVTG.DE is to receive around $100 million upfront following the closing of the sale of private Germany-based Tubulis to Gilead, the company said on Tuesday.Gilead GILD.O said it would acquire Tubulis for up to $5 billion, as the U.S. drugmaker looks ...Reuters
33 minutes ago
Italy likely to replace CEO of defence group Leonardo, sources say
By Giuseppe Fonte and Elvira Pollina ROME, April 7 (Reuters) - Italy is likely to replace Roberto Cingolani as chief executive of defence group Leonardo LDOF.MI, two sources close to the matter told Reuters, in what would be a major change in a round of appointments at state-controlled companies....Reuters
33 minutes ago
Gilead to buy Germany's Tubulis for up to $5 billion to boost cancer pipeline
April 7 (Reuters) - Gilead GILD.O said on Tuesday it would acquire private Germany-based Tubulis GmbH for up to $5 billion, as the U.S. drugmaker looks to boost its pipeline with a lucrative class of experimental cancer drugs referred to as "guided missiles".This marks the latest in Gilead&#...Reuters
35 minutes ago
CANADA FX DEBT - Canadian dollar weakens, benchmark yield climbs
The Canadian dollar weakened against the greenback on Tuesday, and the yield on benchmark government debt climbed. The loonie CAD= was trading 0% lower at C$1.3914 to the greenback, or 71.87 U.S. cents, after trading in a range of 1.3907 to 1.3929.Canadian government 10-year bond yields CA10YT=RR ro...Reuters
35 minutes ago
Uber bets on Amazon's custom chips to boost AI efforts
April 7 (Reuters) - Uber UBER.N is using Amazon's AMZN.O custom chips to speed up computing and train artificial intelligence models, the cloud giant said on Tuesday, as the ride-hailing firm seeks advanced hardware to handle growing digital workloads.The deal expands the companies' existing...Reuters
35 minutes ago
Outlook Therapeutics Announces Formal Dispute Resolution Request For Ons-5010/Lytenava™ (Bevacizumab-Vikg) Accepted By FDA
April 7 (Reuters) - Outlook Therapeutics Inc OTLK.O:OUTLOOK THERAPEUTICS ANNOUNCES FORMAL DISPUTE RESOLUTION REQUEST FOR ONS-5010/LYTENAVA™ (BEVACIZUMAB-VIKG) ACCEPTED BY FDAOUTLOOK THERAPEUTICS INC - FDA ACCEPTS OUTLOOK THERAPEUTICS' DISPUTE RESOLUTION REQUEST FOR ONS-5010/LYTENAVA; MEETING IN ...Reuters
40 minutes ago
WRAPUP 6-'A whole civilisation will die' says Trump as Iran defies looming deadline
Tehran rejects temporary ceasefire, senior Iranian source saysIran says Pakistani mediation efforts at critical stageIsrael warns Iranians to stay away from trains and railways Deadline approaches on Trump's threat to hit infrastructureIranian media report strike on synagogue in TehranBy Parisa ...Reuters
42 minutes ago
RPT-Novo Nordisk launches higher-dose Wegovy in the United States
April 7 (Reuters) - Novo Nordisk NOVOb.CO said on Tuesday that it has made a higher-dose version of its blockbuster weight-loss drug Wegovy available across the United States.The 7.2-milligram dose, branded as Wegovy HD, gained approval under the FDA Commissioner's National Priority Review Vouch...Reuters
45 minutes ago
Aurobindo Pharma Says Co Receives USFDA Approval For Dapagliflozin Tablets, 5 Mg And 10 Mg
April 7 (Reuters) - Aurobindo Pharma Ltd ARBN.NS:AUROBINDO PHARMA - AUROBINDO PHARMA RECEIVES USFDA APPROVAL FOR DAPAGLIFLOZIN TABLETS, 5 MG AND 10 MGAUROBINDO PHARMA - ELIGIBLE FOR 180 DAYS SHARED GENERIC DRUG EXCLUSIVITY FOR DAPAGLIFLOZIN TABLETSSource text: https://tinyurl.com/rdf89uy8Reuters
47 minutes ago
Hermeus Reaches $1 Billion Valuation With $350 Million Raise To Build Today's Fastest Aircraft For The American Warfighter
April 7 (Reuters) - HERMEUS REACHES $1 BILLION VALUATION WITH $350 MILLION RAISE TO BUILD TODAY'S FASTEST AIRCRAFT FOR THE AMERICAN WARFIGHTERHERMEUS: ROUND LED BY KHOSLA VENTURES, CONTINUED SUPPORT FROM CANAAN PARTNERS, FOUNDERS FUND, RTX VENTURES, BLING CAPITAL, AND IN-Q-TELFurther company cov...Reuters
49 minutes ago
